Biocon Limited launched a new drug for treatment of diabetes. The new drug known as 'Basalog' can treat patients suffering from both type one and type two diabetes.

Biocon's Kiran Mazumdar-Shaw said that the key advantage of Basalog is that it replaces other insulins that do not act for 24 hours requiring a diabetic to take multiple shots in a day. Basalog could be used just once in a day.